Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 82 results for "astrazeneca"

AstraZeneca gets extension for Meronem withdrawal till Aug 31
Money Control

Volumes jump at GE Power India counter

Kajaria Ceramics, Crompton Greaves Consumer Electricals, Shree Cement and Astrazeneca Pharma India are among the other stocks to see a surge in volumes on BSE today, 24 August 2017. Business Standard, 1 month ago

120 images for astrazeneca

Sify, 2 weeks ago
Money Control, 1 month ago
Money Control, 2 months ago
Money Control, 3 months ago
Money Control, 3 months ago
Reuters, 4 months ago
Reuters, 4 months ago
Money Control, 4 months ago
Reuters, 4 months ago
Reuters, 4 months ago

AstraZeneca says CEO Pascal Soriot will host earnings call

By Kate Holton and Paul Sandle LONDON (Reuters) - Anglo-Swedish pharmaceutical firm AstraZeneca said on Friday its chief executive, Pascal Soriot, would host a results call with reporters on July 27, after refusing to comment on speculation this week that he ...
 Sify2 months ago AstraZeneca's silence on CEO helps wipe out 3 billion pounds  Business Standard2 months ago
[x]  
Money Control

Positive lung drug trial opens path to U.S. market for Circassia

LONDON (Reuters) - AstraZeneca said its drug Duaklir improved lung function in chronic obstructive pulmonary disease (COPD) patients in a new study, paving the way for likely approval in the U.S., where the commercial rights are held by Britain's Circassia.
 Reuters2 weeks ago AstraZeneca Pharma gains 3% on plan to launch lung cancer drug in India  Money Control2 months ago

FDA widens holds on immunotherapy combination blood cancer trials

(Reuters) - U.S. health regulators stopped five blood cancer trials testing AstraZeneca Plc's immunotherapy Imfinzi in combination with Celgene Corp medicines from accepting new patients and halted another study entirely, the companies said on Thursday.
 Reuters2 weeks ago New data boosts case for extended use of AstraZeneca heart drug  Reuters1 month ago FDA expands use of AstraZeneca/Merck ovarian cancer drug  Reuters1 month ago AstraZeneca gets breakthrough status for blood cancer drug  Reuters1 month ago
Sify

AstraZeneca CEO not signing UK govt Brexit letter

Deep uncertainty about future terms of trade just 18 months before Brexit happens in March 2019
 Business Standard2 weeks ago AstraZeneca CEO, worried by Brexit, not signing UK govt letter  Reuters2 weeks ago

AstraZeneca rebuilds cancer drug hopes with new lung data

MADRID (Reuters) - Two AstraZeneca drugs tackling lung cancer in different ways delivered impressive clinical results on Saturday, helping the British group offset July's big clinical trial setback in the disease.
 Business Standard2 weeks ago

AstraZeneca shares plunge 16% as lung cancer study fails

The two injectable immunotherapy drugs failed to help patients in an advanced lung cancer trial
 Business Standard2 months ago AstraZeneca pain weighs on FTSE, Diageo makes merry after results  DNA2 months ago AstraZeneca slump dominates European shares on busy earnings day  DNA2 months ago Bristol-Myers shares fall after failed AstraZeneca drug trial  Reuters2 months ago
[x]  

Nikkei recovers from near 4-month low after North Korea fears ebb

* Exporters gain ground * Takeda soars on news of tie-up with AstraZeneca By Ayai Tomisawa TOKYO, Aug 30 (Reuters) - Japan's Nikkei share averagerebounded on Wednesday morning, recovering from a nearfour-month low as Wall Street rose and the yen weakened ...
 Sify3 weeks ago

AstraZeneca holds Britain's FTSE back, Carillion loses last 'buy' rating

British shares underperformed in Europe on Thursday, with AstraZeneca weighing on the healthcare sector and BP and Royal Dutch Shell tracking crude prices lower.
 DNA2 months ago

France's Neovacs takes on GSK and AstraZeneca in battle to treat lupus

French biotech company Neovacs is confident that its experimental drug to treat lupus could grab significant market share from standard treatments of the auto-immune disease, its chief executive said. About 5 million people globally suffer from some form of ...
 Reuters1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less